| HOME >> BIOLOGY >> TECHNOLOGY |
ROCHESTER, N.Y., May 1 /PRNewswire/ -- Bio-Optronics announced Thursday that a majority of the company's shares had been acquired by Dan Kerpelman, who will be joining the healthcare workflow technology company as President and CEO.
Kerpelman brings over thirty years of executive experience to Bio-Optronics, a healthcare workflow technology provider with headquarters in Rochester, NY. The company's product portfolio includes innovative workflow management and optimization solutions for hospitals, specialty medical practices and clinical researchers. Kerpelman plans to lead the company through an expansion of its current product offerings and into new markets both within the U.S. and Europe.
Kerpelman explained the decision to join Bio-Optronics by saying, "I've been seeking to leverage my multinational healthcare technology experience in a more entrepreneurial environment. I am so pleased and proud to partner with Mike Kamish and his team. Their innovative products and services have created solutions to some of healthcare's most challenging problems, and we are all enthusiastic to work together to take Bio-Optronics to new heights."
The company's former President and CTO, Mike Kamish, will remain in the role of Vice President and CTO. Kamish said, "We are delighted with Dan's commitment to Bio-Optronics. His experience in the field of healthcare technology and his management experience at GE Healthcare, Kodak Health Imaging, and SGS will be a tremendous asset to the future growth of the company."
Later this month, the company will introduce a new corporate logo, product branding scheme and website, emphasizing its focus on innovative healthcare workflow technology.
About Dan Kerpelman
Dan Kerpelman has thirty years of professional experience, mostly in
healthcare technology. He was recently CEO of the Societe Generale de
Surveillance in Geneva, Switzerland where he led a $3.5B services company
of 46,000 employees, inc
'/>"/>
| SOURCE Bio-Optronics Copyright©2008 PR Newswire. All rights reserved |